1. Дедов И. И., Семичева Т. В., Петеркова В. А. Половое развитие детей: норма и патология / И. И. Дедов, Т. В. Семичева, В. А. Петеркова, М: Колор Ит Студио, 2002. 232 c.
2. Макрецкая Н. А. [и др.]. Клиническая и молекулярно-генетическая характеристика случаев изолированного гипогонадотропного гипогонадизма, обусловленного дефектами рецептора гонадотропин-рилизинг-гормона // Проблемы Эндокринологии. 2021. № 3 (67). C. 62-67.
3. Уварова Е. [и др.]. Показания и особенности использования гестагена дидрогестерона в пубертатном периоде // Репродуктивное здоровье детей и подростков. 2014. № 2 (55). C. 48-58.
4. Abitbol L., Zborovski S., Palmert M. R. Evaluation of delayed puberty: what diagnostic tests should be performed in the seemingly otherwise well adolescent? // Archives of Disease in Childhood. 2016. № 8 (101). C. 767-771.
5. Acerini C. L. [идр.]. The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort // Archives of Disease in Childhood. 2009. № 11 (94). C. 868-872.
6. Adan L. [идр.]. Plasma inhibin B and antimullerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay // Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2010. № 11 (16). C. CR511-517.
7. Aksglaede L. [идр.]. Changes in anti-Mullerian hormone (AMH) throughout the life span: a populationbased study of 1027 healthy males from birth (cord blood) to the age of 69 years // The Journal of Clinical Endocrinology and Metabolism. 2010. № 12 (95). C. 5357-5364.
8. Ankarberg-Lindgren C. [идр.]. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls // The Journal of Clinical Endocrinology and Metabolism. 2001. № 7 (86). C. 3039-3044.
9. Arisaka O. [идр.]. Systemic effects of transdermal testosterone for the treatment of microphallus in children // Pediatrics International: Official Journal of the Japan Pediatric Society. 2001. № 2 (43). C. 134-136.
10. Bang A. K. [идр.]. Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels // European Journal of Endocrinology. 2017. № 4 (176). C. 379-391.
11. Barrio R. [идр.]. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism // Fertility and Sterility. 1999. № 2 (71). C. 244-248.
12. Behre H. M. [идр.]. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men // The Journal of Clinical Endocrinology and Metabolism. 1997. № 8 (82). C. 23862390.
13. Ben-Galim E., Hillman R. E., Weldon V. V. Topically applied testosterone and phallic growth. Its effects in male children with hypopituitarism and microphallus // American Journal of Diseases of Children (1960). 1980. № 3 (134). C. 296-298.
14. Bertelloni S. [идр.]. Androgen therapy in hypogonadal adolescent males // Hormone Research in Paediatrics. 2010. № 4 (74). C. 292-296.
15. Bhasin S. [идр.]. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline // The Journal of Clinical Endocrinology & Metabolism. 2018. № 5 (103). C. 17151744.
16. Bin-Abbas B. [идр.]. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated // The Journal of Pediatrics. 1999. № 5 (134). C. 579-583.
17. Boehm U. [идр.]. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment // Nature Reviews. Endocrinology. 2015. № 9 (11). C. 547-564.
18. Boehm U. [идр.]. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment // Nature Reviews. Endocrinology. 2015. № 9 (11). C. 547-564.
19. Boisen K. A. [идр.]. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries // Lancet (London, England). 2004. № 9417 (363). C. 1264-1269.
20. Bry-Gauillard H. [идр.]. Anti-Mullerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH // The Journal of Clinical Endocrinology and Metabolism. 2017. № 4 (102). C. 1102-1111.
21. Burstein S., Grumbach M. M., Kaplan S. L. Early determination of androgen-responsiveness is important in the management of microphallus // Lancet (London, England). 1979. № 8150 (2). C. 983986.
22. Canale D. [идр.]. Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patients // Molecular and Cellular Endocrinology. 2000. № 1-2 (161). C. 4751.
23. Celik O. [идр.]. Ghrelin action on GnRH neurons and pituitary gonadotropes might be mediated by GnIH-GPR147 system // Hormone Molecular Biology and Clinical Investigation. 2016. № 2 (25). C. 121128.
24. Chada M. [идр.]. Inhibin B, Follicle Stimulating Hormone, Luteinizing Hormone, and Estradiol and Their Relationship to the Regulation of Follicle Development in Girls during Childhood And Puberty 2003. (52). C. 6.
25. Chellakooty M. [идр.]. Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls // The Journal of Clinical Endocrinology and Metabolism. 2003. № 8 (88). C. 3515-3520.
26. Close S. [идр.]. Phenotype and Adverse Quality of Life in Boys with Klinefelter Syndrome // The Journal of Pediatrics. 2015. № 3 (167). C. 650-657.
27. Costa-Barbosa F. A. [идр.]. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes // The Journal of Clinical Endocrinology and Metabolism. 2013. № 5 (98). C. E943-953.
28. Coutant R. [идр.]. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty // The Journal of Clinical Endocrinology and Metabolism. 2010. № 12 (95). C. 5225-5232.